Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Neuro Endocrinol Lett ; 34(1): 9-13, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23524618

RESUMO

We present a 39-year-old woman who was previously diagnosed with Von Hippel Lindau Disease (VHLD). She had surgery and radiotherapy for cranial hemangioblastoma (HA) 11 years ago and had unilateral adrenalectomy for pheochromocytoma in another hospital 6 month prior to her admission to our center. Moon face, buffalo hump, central obesity, progressive weight gain and menstrual irregularities persisted after adrenalectomy. Her laboratory results were consistent with ectopic Cushing's syndrome (ECS). A pancreatic solid mass with a nodule on the left lung were revealed upon computed tomography. In addition, Gallium-68 Somatostatin Receptor PET confirmed the pancreatic involvement and demonstrated additional lesions on the left lung and in the aortocaval lymphatic system on the right side, suggesting metastatic pancreatic neuroendocrine tumor (PNET). Peptide receptor radionuclide therapy (PRRT) with [177Lutetium-DOTA0,Tyr3] octreotate was performed on the patient, with no side effects observed. She was discharged from the hospital 10 days after the first cycle.


Assuntos
Carcinoma Neuroendócrino/complicações , Síndrome de Cushing/etiologia , Neoplasias Pancreáticas/complicações , Doença de von Hippel-Lindau/complicações , Adulto , Carcinoma Neuroendócrino/radioterapia , Carcinoma Neuroendócrino/secundário , Síndrome de Cushing/radioterapia , Feminino , Humanos , Lutécio/uso terapêutico , Neoplasias Pancreáticas/patologia , Neoplasias Pancreáticas/radioterapia , Peptídeos Cíclicos/uso terapêutico , Radioisótopos/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA